Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bisacodyl + simeticone
- Development stage
- Unknown
- Lead developer
- Boehringer Ingelheim
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Bisacodyl + simeticone is a fixed-dose combination therapy designed to address both constipation and the associated symptom of bloating. Bisacodyl is a diphenylmethane derivative stimulant laxative that acts directly on the colonic mucosa to stimulate sensory nerve endings, thereby increasing peristalsis and promoting bowel movements. Simeticone (also known as simethicone) is an orally administered anti-foaming agent that acts mechanically by reducing the surface tension of gas bubbles in the gastrointestinal tract, allowing them to coalesce and be passed more easily. This combination provides a dual-action approach: bisacodyl offers overnight relief from constipation, while simeticone provides immediate relief from gas-related discomfort and bloating. The combination has been evaluated in clinical trials (such as NCT02211976) and is typically used in over-the-counter (OTC) gastrointestinal products.
- Brand names
- Dulcolax Bloating ReliefDulcolax Multi-Symptom
- Other names
- bisacodyl and simeticonebisacodyl and simethiconebisacodyl + simethicone
Beyond the preview
Go deeper on bisacodyl + simeticone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bisacodyl + simeticone.